TherapeuticsMD, Inc.

TXMD Nasdaq SEC CIK 25743
Follow TherapeuticsMD Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.3M +60.6% vs same quarter last year
Net income $491K +223% vs same quarter last year
EPS, diluted $0.04 +300% vs same quarter last year
Operating cash flow $1.3M +26.9% vs same quarter last year
Revenue by quarter
$667K
$393K
$952K
$784K
$893K
$724K
$869K
$1.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$3M−$569K
FY24$1.8M−$2.2M
FY23$1.3M−$10.3M
FY22$70M$112M
FY21$2.6M−$172.4M
FY20$64.9M−$183.5M
FY19$49.6M−$176.1M
FY18$16.1M−$132.6M
FY17$16.8M−$76.9M
FY16$19.4M−$89.9M
FY15$20.1M−$85.1M
FY14$15M−$54.2M
FY13$8.8M−$28.4M
FY12$3.8M−$35.1M
FY11$2.1M−$12.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−145.3%−18.8%
FY24-−347.1%−123.9%
FY23100%−654.6%−789.4%
FY2298%1.7%160.1%
FY2145.5%−3092.8%−6700.9%
FY2075.4%−239.8%−282.9%
FY1987.2%−304.6%−354.8%
FY1883%−808.8%−823.7%
FY1784.3%−462.7%−458.5%
FY1678.4%−466.3%−464.3%
FY1577.6%−422.9%−422.4%
FY1475.6%−359.6%−360.8%
FY1377.7%−294.1%−323.8%
FY1264.7%−423%−919.9%
FY1154.6%−259.9%−618.4%
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22-
FY21−$142.7M
FY20−$159.7M
FY19−$168.2M
FY18−$107M
FY17−$76.2M
FY16−$69.5M
FY15−$79.2M
FY14−$45.6M
FY13−$20.8M
FY12−$12.8M
FY11−$5M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • TherapeuticsMD
  • Healthcare median
−8000%−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearTherapeuticsMDHealthcare median
FY25−18.8%−30.6%
FY24−123.9%−47%
FY23−789.4%−58%
FY22160.1%−80.4%
FY21−6700.9%−71.8%
FY20−282.9%−62.2%
FY19−354.8%−46.2%
FY18−823.7%−49.6%
FY17−458.5%−45.9%
FY16−464.3%−36%
FY15−422.4%−37.8%
FY14−360.8%−35.5%
FY13−323.8%−37.1%
FY12−919.9%−29.1%
FY11−618.4%−27.9%